UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by ...

Scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ones.

Data from a new study shows that the anti-inflammation drug, dexamethasone, may inhibit the immune system's ability to fight brain tumors.

New findings could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most common ...

UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by ...

The fast-paced scientific discoveries over the last 30-years have advanced the field of medicine and improved millions of patient lives. Specifically, immu | Immunology ...

Researchers find four coordinated gene expression programs in immune cells from glioma tumors, including two that could lead ...

Identifying splicing-related neoantigens in gliomas opens new avenues for immunotherapy, enhancing treatment strategies for ...

Kairos Pharma (KAPA) announced that the company presented preclinical data on its investigational compounds KROS 101 and KROS 401 during the ...

Swelling caused by brain cancer is a serious problem that can lead to serious side effects and even death. While controlling ...